Aerie Pharmaceuticals PE Ratio 2012-2019 | AERI

Current and historical p/e ratio for Aerie Pharmaceuticals (AERI) from 2012 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Aerie Pharmaceuticals PE ratio as of January 23, 2020 is 0.00.
Aerie Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-01-23 22.56 0.00
2019-09-30 19.22 $-4.33 0.00
2019-06-30 29.55 $-5.20 0.00
2019-03-31 47.50 $-5.56 0.00
2018-12-31 36.10 $-5.55 0.00
2018-09-30 61.55 $-6.01 0.00
2018-06-30 67.55 $-4.94 0.00
2018-03-31 54.25 $-4.36 0.00
2017-12-31 59.75 $-4.07 0.00
2017-09-30 48.60 $-3.34 0.00
2017-06-30 52.55 $-3.26 0.00
2017-03-31 45.35 $-3.31 0.00
2016-12-31 37.85 $-3.40 0.00
2016-09-30 37.74 $-3.29 0.00
2016-06-30 17.60 $-3.17 0.00
2016-03-31 12.16 $-3.03 0.00
2015-12-31 24.35 $-2.88 0.00
2015-09-30 17.74 $-2.81 0.00
2015-06-30 17.65 $-2.66 0.00
2015-03-31 31.34 $-2.42 0.00
2014-12-31 29.19 $-2.00 0.00
2014-09-30 20.69 $-1.93 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.045B $0.024B
Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It is focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's lead `Dual- Action` product and `Triple-Action` products are under developmental stages. Aerie Pharmaceuticals, Inc. is headquartered in Bedminster, New Jersey.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.891B 39.41
Takeda Pharmaceutical (TAK) Japan $62.405B 9.86
Astellas Pharma (ALPMY) Japan $32.771B 16.37
Eisai (ESALY) Japan $21.953B 42.32
Merck (MKGAF) Germany $16.705B 22.80
Grifols, S.A (GRFS) Spain $15.965B 20.92
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Neurocrine Biosciences (NBIX) United States $9.410B 444.24
Catalent (CTLT) United States $9.008B 36.65
Ionis Pharmaceuticals (IONS) United States $8.496B 17.21
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.435B 10.77
IPSEN SA ADR (IPSEY) France $7.632B 0.00
STADA ARZNEIMI (STDAF) Germany $5.991B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.540B 0.00
Hypermarcas (HYPMY) Brazil $5.336B 16.23
Arrowhead Pharmaceuticals (ARWR) United States $4.423B 66.97
Evotec AG (EVTCY) Germany $4.301B 69.51
United Therapeutics (UTHR) United States $3.988B 0.00
FibroGen (FGEN) United States $3.853B 113.23
Nektar Therapeutics (NKTR) United States $3.830B 0.00
Sage Therapeutics (SAGE) United States $3.651B 0.00
PTC Therapeutics (PTCT) United States $3.287B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.239B 11.92
Zogenix (ZGNX) United States $2.404B 0.00
ChemoCentryx (CCXI) United States $2.365B 0.00
Tilray (TLRY) Canada $2.128B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.128B 0.00
Heron Therapeutics (HRTX) United States $2.107B 0.00
Xencor (XNCR) United States $2.043B 62.09
Ironwood Pharmaceuticals (IRWD) United States $2.012B 64.15
Pacira Pharmaceuticals (PCRX) United States $1.834B 54.25
USANA Health Sciences (USNA) United States $1.659B 17.70
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.522B 10.39
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
Corcept Therapeutics (CORT) United States $1.501B 18.24
Endo (ENDP) Ireland $1.496B 2.75
Theravance Biopharma (TBPH) Cayman Islands $1.468B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.109B 25.23
Karyopharm Therapeutics (KPTI) United States $1.089B 0.00
Portola Pharmaceuticals (PTLA) United States $1.070B 0.00
Dermira (DERM) United States $1.023B 0.00
Akebia Therapeutics (AKBA) United States $1.019B 0.00
Radius Health (RDUS) United States $0.873B 0.00
ImmunoGen (IMGN) United States $0.734B 0.00
Collegium Pharmaceutical (COLL) United States $0.710B 0.00
TherapeuticsMD (TXMD) United States $0.694B 0.00
Flexion Therapeutics (FLXN) United States $0.687B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.553B 0.00
Molecular Templates (MTEM) United States $0.531B 0.00
Translate Bio (TBIO) United States $0.522B 0.00
Ardelyx (ARDX) United States $0.475B 0.00
Organogenesis Holdings (ORGO) United States $0.470B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.454B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.445B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.444B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.433B 52.50
Innate Pharma SA (IPHYF) France $0.432B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.431B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.427B 18.40
Siga Technologies (SIGA) United States $0.422B 9.65
DURECT (DRRX) United States $0.404B 0.00
Lannett Co Inc (LCI) United States $0.395B 4.60
OptiNose (OPTN) United States $0.371B 0.00
Calithera Biosciences (CALA) United States $0.371B 0.00
Harpoon Therapeutics (HARP) United States $0.369B 0.00
Recro Pharma (REPH) United States $0.369B 0.00
Rafael Holdings (RFL) United States $0.356B 0.00
Indivior (INVVY) United States $0.339B 1.23
Spectrum Pharmaceuticals (SPPI) United States $0.324B 0.00
KalVista Pharmaceuticals (KALV) United States $0.322B 0.00
Concert Pharmaceuticals (CNCE) United States $0.304B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.282B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.261B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.246B 0.00
MEI Pharma (MEIP) United States $0.239B 0.00
Ocular Therapeutix (OCUL) United States $0.225B 0.00
IMV INC (IMV) Canada $0.222B 0.00
Jounce Therapeutics (JNCE) United States $0.217B 2.90
La Jolla Pharmaceutical (LJPC) United States $0.209B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 32.83
Taiwan Liposome (TLC) Taiwan $0.171B 0.00
Xeris Pharmaceuticals (XERS) United States $0.163B 0.00
CannTrust Holdings (CTST) Canada $0.157B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.143B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.136B 0.00
Redhill Biopharma (RDHL) Israel $0.130B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.128B 0.00
CV Sciences (CVSI) United States $0.117B 0.00
Otonomy (OTIC) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.107B 0.00
PolarityTE (PTE) United States $0.106B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.099B 0.00
Champions Oncology (CSBR) United States $0.099B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.094B 0.00
Neos Therapeutics (NEOS) United States $0.087B 0.00
Infinity Pharmaceuticals (INFI) United States $0.087B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 22.82
RENEURON GP (RNUGF) United Kingdom $0.074B 0.00
CTI BioPharma (CTIC) United States $0.073B 0.00
AgeX Therapeutics (AGE) United States $0.070B 0.00
Aclaris Therapeutics (ACRS) United States $0.066B 0.00
Natural Alternatives (NAII) United States $0.066B 16.49
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
Nivalis Therapeutics (ALPN) United States $0.060B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
IsoRay (ISR) United States $0.057B 0.00
Onconova Therapeutics (ONTX) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
Jaguar Animal Health (JAGX) United States $0.041B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
India Globalization Capital (IGC) United States $0.027B 0.00
VAXART, INC (VXRT) United States $0.025B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.018B 0.00
Novan (NOVN) United States $0.018B 0.00
Shineco (TYHT) China $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Lipocine (LPCN) United States $0.013B 0.00
Flex Pharma (SLRX) United States $0.013B 0.00
Vical (BBI) United States $0.012B 0.00
Heat Biologics (HTBX) United States $0.011B 0.00
Hemispherx BioPharma (AIM) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00